OBJECTIVE: To describe 15 pediatric patients with opiate-induced respi
ratory depression. DESIGN: In-house adverse drug reaction (ADR) report
forms were reviewed to identify any patients with suspected opiate-in
duced respiratory depression. Case review was then performed. SETTING:
Large pediatric teaching hospital with regional specialties. PATIENTS
: Fifteen patients aged 2 days to 17 years (median 14 mo). MAIN OUTCOM
E MEASURES: Respiratory depression resulting in apnea, hypoxia, cyanos
is, reduced respiratory rate, or the need for naloxone following or du
ring opiate administration was recorded. RESULTS: Fifteen patients exp
erienced some degree of respiratory depression over the 3 years of sur
veillance. Treatment included naloxone (12 patients), admission to the
pediatric intensive care unit (8), ventilation (5), and reduction in
dosage (1). Predisposing factors for respiratory depression included a
n age of less than 1 year, excessive dosage, concurrent medical proble
ms, concurrent drugs, and medication errors. CONCLUSIONS: Opiate-induc
ed respiratory depression in pediatric patients occurs infrequently, b
ut may have serious consequences. Opiates are potent analgesics that c
hildren require and should receive. Safe use of opiates in pediatric p
atients, however, depends on the dosage, route and method of administr
ation, consideration of any predisposing factors, and adequate monitor
ing. This article highlights some of the problems with opiate use in c
hildren and gives some recommendations on bow these problems may be pr
evented.